General MedicationsTOPICALGeneric

BACITRACIN ZINC-NEOMYCIN SULFATE-POLYMYXIN B SULFATE

BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE

Standard Dose

400 UNITS/GM;EQ 3.5MG BASE/GM;5,000 UNITS/GM

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview BACITRACIN ZINC-NEOMYCIN SULFATE-POLYMYXIN B SULFATE is listed in Drugs@FDA under application 062833 (ANDA).

Marketing status: Discontinued Active ingredient BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE Form and strength OINTMENT;TOPICAL - 400 UNITS/GM;EQ 3.5MG BASE/GM;5,000 UNITS/GM Sponsor NASKA Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview BACITRACIN ZINC-NEOMYCIN SULFATE-POLYMYXIN B SULFATE is listed in Drugs@FDA under application 062833 (ANDA). Marketing status: Discontinued Active ingredient BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE Form and strength OINTMENT;TOPICAL - 400 UNITS/GM;EQ 3.5MG BASE/GM;5,000 UNITS/GM Sponsor NASKA Submission history See approval history documents.

Monitoring

• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.